Oncology
Medical Oncologist and Systemic Cancer Therapy Specialist in Mumbai17 Years
HCG Cancer Hospital
Mumbai
Dr. Nirmal Vivek Raut is an experienced Consultant Medical Oncologist practicing at HCG Cancer Hospital, Borivali, Mumbai. He has extensive expertise in the medical management of solid tumours and hematological malignancies using chemotherapy, immunotherapy, targeted therapy and other evidence-based systemic cancer treatments.
He completed his MBBS from Seth G.S. Medical College, Mumbai, followed by postgraduate training in Radiation Oncology and senior residency in Medical Oncology at Tata Memorial Hospital. He later completed advanced training in molecular oncology and obtained European Certification in Medical Oncology.
Dr. Nirmal Raut has a strong academic foundation in precision oncology and molecular cancer medicine. His Masters in Molecular Oncology and international oncology certification support his ability to integrate tumour biology, molecular testing and modern systemic therapy into personalised treatment planning.
His clinical expertise includes the treatment of breast cancer, lung cancer, gastrointestinal malignancies, head and neck cancers, genitourinary cancers and other solid tumours. He also manages hematological malignancies such as lymphoma, leukemia and multiple myeloma.
Dr. Nirmal Raut is experienced in chemotherapy, targeted therapy and immunotherapy. Treatment selection is based on cancer type, stage, molecular characteristics, previous treatments and the overall health of the patient.
He also has extensive involvement in oncology research and clinical trials. His academic work has been published in recognised oncology journals, and his training in clinical research helps him evaluate newer evidence-based cancer therapies.
Dr. Nirmal Raut follows a patient-centred approach to cancer care. He focuses on explaining the diagnosis, expected outcomes, available treatment options and potential side effects clearly so that patients and families can actively participate in treatment decisions.
Chemotherapy uses anti-cancer medicines to destroy or control cancer cells. Dr. Nirmal Raut selects chemotherapy regimens based on the cancer type, disease stage, patient condition and previous treatment history.
Immunotherapy helps activate or enhance the body's immune system to recognise and attack cancer cells. It may be recommended for selected cancers based on biomarkers, disease stage and individual clinical factors.
Targeted therapy works against specific molecular changes or proteins that contribute to cancer growth. Molecular testing may help identify patients who are suitable for particular targeted medicines.
Precision oncology uses information about a tumour's molecular and genetic characteristics to help guide treatment decisions. Dr. Nirmal Raut's advanced training in molecular oncology supports personalised cancer treatment planning.
Medical treatment for breast cancer may include chemotherapy, targeted therapy, immunotherapy or hormonal treatment depending on cancer subtype, receptor status, stage and other clinical findings.
Dr. Nirmal Raut provides systemic treatment for lung cancer using chemotherapy, immunotherapy and targeted therapy. Biomarker and molecular testing may help determine the most appropriate treatment for selected patients.
He provides systemic therapy for gastrointestinal cancers including selected cancers of the stomach, colon, rectum, pancreas and other digestive organs, often as part of a multidisciplinary treatment plan.
Systemic therapy for head and neck cancers may include chemotherapy, immunotherapy or targeted treatment and can be combined with surgery or radiation therapy depending on disease stage.
Medical oncology treatment for cancers involving the prostate, kidney, bladder and other urinary organs may include chemotherapy, hormonal treatment, immunotherapy or targeted therapy based on the diagnosis.
Lymphoma treatment may involve chemotherapy, targeted medicines, immunotherapy or other systemic therapies depending on whether the patient has Hodgkin lymphoma, non-Hodgkin lymphoma or another subtype.
Dr. Nirmal Raut manages selected leukemia cases using evidence-based systemic therapies tailored to the leukemia subtype, disease risk, patient age and overall medical condition.
Multiple myeloma treatment may include combinations of targeted medicines, immunomodulatory drugs, chemotherapy and other systemic therapies depending on disease characteristics and patient fitness.
MBBS, MD (Radiotherapy), European Certification of Medical Oncology, Professional Diploma in Clinical Research, Masters in Molecular Oncology
Chemotherapy, Immunotherapy, Targeted Therapy, Precision Oncology, Molecular Oncology, Solid Tumor Treatment, Hematological Cancer Treatment, Breast Cancer Treatment, Lung Cancer Treatment
Genuine patient experiences and treatment feedback.
Quick answers to common questions about Dr. Nirmal Vivek Raut
Dr. Nirmal Raut is a Consultant Medical Oncologist at HCG Cancer Hospital, Borivali, Mumbai. He specialises in systemic treatment for solid tumours and hematological malignancies
Dr. Nirmal Raut has completed MBBS, MD, European Certification of Medical Oncology, advanced training in molecular oncology and a Professional Diploma in Clinical Research. HCG
HCG currently lists Dr. Nirmal Raut with 17 years of experience. Practo separately reports more than 24 years of overall medical experience
Dr. Nirmal Raut practices at HCG Cancer Hospital, Borivali, Mumbai. Other current or recent listings also associate him with hospitals including Bhaktivedanta Hospital, Apex Hospital and Holy Spirit Hospital.
He treats a broad range of solid tumours and hematological malignancies using medical oncology treatments such as chemotherapy, targeted therapy and immunotherapy
Contact us for personalized help or to schedule an appointment.